Intensity Therapeutics, Inc. (INTS)

Intensity Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for INTS stock has a target of 12, which predicts an increase of 205.73% from the current stock price of 3.93.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$12	$12	$12	$12
Change	+205.73%	+205.73%	+205.73%	+205.73%

* Price targets were last updated on Mar 21, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for INTS is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	0	0	0	0	0
Buy	1	1	1	1	1
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Wasserman Benchmark	Benchmark	Buy Reiterates $12	Buy	Reiterates	$12	+205.73%	Mar 21, 2024
Robert Wasserman Benchmark	Benchmark	Buy Reiterates $12	Buy	Reiterates	$12	+205.73%	Nov 14, 2023
Robert Wasserman Benchmark	Benchmark	Buy Reiterates $12	Buy	Reiterates	$12	+205.73%	Aug 24, 2023
Robert Wasserman Benchmark	Benchmark	Buy Initiates $12	Buy	Initiates	$12	+205.73%	Jul 18, 2023

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -0.94

Year	2019	2020	2021	2022	2023	2024
Revenue	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-
EPS	-1.58	-1.76	-2.32	-2.22	-1.38	-0.94
EPS Growth	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2024
High	-
Avg	-
Low	-

EPS Forecast

EPS	2024
High	-0.97
Avg	-0.94
Low	-0.90

EPS Growth

EPS Growth	2024
High	-
Avg	-
Low	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.